Paul Straub

Active Investor

Director at Claremont Creek Ventures

Oakland, California

Paul Straub, Director at Claremont Creek Ventures is an active investor based in Oakland, California. This profile covers what Paul Straub backs, at which stage, and how founders can reach out in 2026.

Paul Straub invests in Healthcare & Biotech, MedTech & Medical Devices, Hardware & Deep Tech and SaaS & Enterprise, typically at Early Stage Venture. Portfolio companies on record include Arcxis Biotechnologies, Tibion Bionic Technologies and Root3 Technologies.

Location
Oakland, California
Typical check
$500K
Past investments
34

What does Paul Straub invest in?

Investor type
VCPE
Stages
Early Stage Venture

Where is Paul Straub based?

Paul Straub is based in Oakland, California.

Browse more startup investors near Paul Straub:
Startup investors in CaliforniaStartup investors in the United States

Which companies has Paul Straub invested in?

Arcxis BiotechnologiesTibion Bionic TechnologiesRoot3 TechnologiesComfyNuMediiFluxion BiosciencesTargetCast NetworksZipline MedicalGenalyteProject FrogPropertyBridgeAlphabet EnergyRenew FinancialBlue PillarGeneWEAVECellScopeecoATMTroveNateraShotSpotterSociogramicsAssurex HealthRidePalClean Power Finance

Plus 10 more companies on record.

How to reach Paul Straub

Angels and operators like Paul Straub reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Reach active investors like this one

Get investor contacts

About this profile

This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.

Cite this page

Round Funded. "Paul Straub." Round Funded investor database, updated October 6, 2026.

Stable URL, it will not change: https://www.roundfunded.com/en/investor/paul-straub

Frequently Asked Questions

Who is Paul Straub?

Paul Straub, Director at Claremont Creek Ventures is an active investor based in Oakland, California. Paul Straub invests in Healthcare & Biotech, MedTech & Medical Devices, Hardware & Deep Tech and SaaS & Enterprise, typically at Early Stage Venture. Portfolio companies on record include Arcxis Biotechnologies, Tibion Bionic Technologies and Root3 Technologies.

What does Paul Straub invest in?

Paul Straub invests in Healthcare & Biotech, MedTech & Medical Devices, Hardware & Deep Tech and SaaS & Enterprise, typically at Early Stage Venture. Match your sector and stage, then reach out with a personalized pitch.

What stage does Paul Straub invest at?

Paul Straub typically invests at Early Stage Venture. Lead with traction that fits the stage when you reach out.

What is Paul Straub's typical check size?

Paul Straub typically writes checks around $500K. Use it as a signal for whether your raise fits their stage.

Where is Paul Straub based?

Paul Straub is based in Oakland, California.

Which companies has Paul Straub invested in?

Companies Paul Straub has backed, according to the Round Funded catalog, include Arcxis Biotechnologies, Tibion Bionic Technologies, Root3 Technologies, Comfy, NuMedii and Fluxion Biosciences.

How do founders reach investors like this?

Round Funded lists active investors with verified, professional contact details for signed-up founders. Filter by sector, stage and location, then send a personalized pitch from your own inbox.

What is Round Funded?

Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.

Similar investors to Paul Straub

Investors who share Paul Straub's portfolio companies, firm, city or investment focus.